Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
156.00    5.00 (3.31%)
Bid:
156.00
Ask:
156.20
Spread: 0.20 (0.128%)
Market Cap: £266.12m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Pre-close Trading Statement

24 Jun 2010 07:00

RNS Number : 1459O
McBride PLC
24 June 2010
Β 

ο»Ώ

24th June 2010

Β 

McBride PLC

Β 

Pre-close Trading Statement

Β 

McBride PLC, Europe's leading provider of private label household and personal care products, today provides an update on trading for the year ended 30 June 2010 prior to entering its closed period.

Β 

The Board expects to report operating profits for the year in line with its expectations.

Β 

The Group anticipates reporting full-year revenue growth, on a constant currency basis, to be flat following a fourth quarter that is expected to be 3% lower than prior year. This reflects ongoing branded promotional activity in UK combined with weak retail sales across Europe.

Β 

The Group is seeing prices for key raw materials increasing by 4% by the end of June compared with December 2009. We believe our markets will remain volatile and there remains a significant risk that our material costs will rise by a further 4-6% during the next financial year. Our business model is designed to manage raw material increases effectively, although inevitably there will be a delay before recovery from customers.

Β 

Year-end net debt is expected to be in line with expectations reflecting continued strong cash flows. In addition, McBride is pleased to announce that a new five-year €175m revolving credit facility agreement has been concluded with our banks on attractive terms.

Β 

As part of the Group's continuing focus on driving operational efficiencies, a further re-structuring project has been initiated in UK and is expected to deliver annualised cost savings of Β£4m with cash expenditure of Β£4m. The cost of this initiative will be treated as an exceptional item, resulting in a total exceptional charge for 2009/10 in the region of Β£14m.

Β 

The group intends to announce its preliminary results for the year ended 30 June 2010 on 2 September 2010.

Β 

Β 

For further information please contact:

Β 

McBride PLC

Chris Bull, Chief Executive

020 7539 7852

Richard Armitage, Group Finance Director

020 7539 7851

Financial Dynamics

Ben Foster

020 7269 7247

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTPGUCAQUPUGAW
Date   Source Headline
29th Sep 20227:00 amRNSPreliminary results timing
6th Sep 20222:51 pmRNSBoard Update
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting
25th Aug 20224:40 pmRNSResult of AGM
22nd Aug 20223:41 pmRNSHolding(s) in Company
15th Aug 20225:48 pmRNSHolding(s) in Company
9th Aug 20227:00 amRNSNotice of General Meeting
14th Jul 20227:00 amRNSFull year trading update
29th Jun 20227:00 amRNSJune 2022 - Bank Covenant Waiver
17th Jun 20224:42 pmRNSSecond Price Monitoring Extn
17th Jun 20224:36 pmRNSPrice Monitoring Extension
9th Jun 20221:55 pmRNSDirector/PDMR Shareholding
24th May 20223:20 pmRNSDirector/PDMR Shareholding
23rd May 202212:31 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSDirector/PDMR Shareholding
25th Apr 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20221:19 pmRNSDirector/PDMR Shareholding
18th Mar 202210:05 amRNSDirector/PDMR Shareholding
7th Mar 202210:03 amRNSDirector/PDMR Shareholding
28th Feb 20225:47 pmRNSDirector/PDMR Shareholding
24th Feb 20225:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20227:00 amRNSHalf-year Report
18th Feb 20227:00 amRNSBoard Changes
22nd Dec 20213:02 pmRNSDecember 2021 - Bank Covenant Waiver
16th Dec 20217:00 amRNSFinancial Year 2022 Trading Update
26th Nov 20219:48 amRNSDirector/PDMR Shareholding
26th Nov 20217:00 amRNSRedemption of B Shares
8th Nov 20212:02 pmRNSDirector/PDMR Shareholding
26th Oct 20213:01 pmRNSDirector/PDMR Shareholding
26th Oct 20212:21 pmRNSDirector/PDMR Shareholding
26th Oct 20211:35 pmRNSDirector/PDMR Shareholding
19th Oct 20216:05 pmRNSResult of AGM
19th Oct 20217:00 amRNSAGM Trading Update
7th Oct 20213:05 pmRNSDirector/PDMR Shareholding
5th Oct 20216:21 pmRNSCorrection to the Annual Report
30th Sep 20216:16 pmRNSRedemption of B Shares
24th Sep 20217:00 amRNSAnnual Report 2021 and Annual General Meeting 2021
13th Sep 20213:27 pmRNSDirector/PDMR Shareholding
7th Sep 20214:05 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSFinal Results
2nd Sep 20215:00 pmRNSTransaction in Own Shares
1st Sep 20215:29 pmRNSTransaction in Own Shares
31st Aug 20215:14 pmRNSTransaction in Own Shares
25th Aug 20215:18 pmRNSTransaction in Own Shares
24th Aug 20215:09 pmRNSTransaction in Own Shares
23rd Aug 20215:33 pmRNSTransaction in Own Shares
20th Aug 20215:00 pmRNSTransaction in Own Shares
19th Aug 20215:49 pmRNSTransaction in Own Shares
19th Aug 20217:00 amRNSFinancial Year 2022 trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.